+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Ipsen SA
  • Laboratoires Thea SA
  • NicOx SA
  • Pfizer Inc
  • Sanofi
  • MORE
Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – A summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Les Laboratoires Servier SAS (Servier) researches, develops, manufactures and markets drugs for treating various diseases. The company's portfolio of marketed products treat central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, women's and male health issues, gastrointestinal diseases, hematological disorders, hormonal disorders and others. It invests substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs). The company also provides generic drugs and contract development and manufacturing services across its global network. It sells its products in Europe, North America, South America, Middle East, Africa and Asia. Servier headquartered in Suresnes, France.

Les Laboratoires Servier SAS Key Recent Developments

Jul 17, 2019: WeHealth Digital Medicine and French start-up Lucine sign partnership to develop digital therapeutics
Jul 16, 2019: Pall chosen as single-source supplier by servier for purpose built end-to-end biomanufacturing facility in Gidy, France
Jun 19, 2019: Servier breaks ground of Servier Paris-Saclay Research Institute
Jun 06, 2019: Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology
Jun 03, 2019: Servier and MBC BioLabs announce winner of the 2019 Servier Golden Ticket

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with a detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ipsen SA
  • Laboratoires Thea SA
  • NicOx SA
  • Pfizer Inc
  • Sanofi
  • MORE
Section 1 - About the Company
  • Les Laboratoires Servier SAS - Key Facts
  • Les Laboratoires Servier SAS - Key Employees
  • Les Laboratoires Servier SAS - Major Products and Services
  • Les Laboratoires Servier SAS - History
  • Les Laboratoires Servier SAS - Company Statement
  • Les Laboratoires Servier SAS - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Les Laboratoires Servier SAS - Business Description
  • Les Laboratoires Servier SAS - Corporate Strategy
  • Les Laboratoires Servier SAS - SWOT Analysis
  • SWOT Analysis - Overview
  • Les Laboratoires Servier SAS - Strengths
  • Les Laboratoires Servier SAS - Weaknesses
  • Les Laboratoires Servier SAS - Opportunities
  • Les Laboratoires Servier SAS - Threats
  • Les Laboratoires Servier SAS - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Les Laboratoires Servier SAS, Recent Deals Summary
Section 4 – Company’s Recent Developments
  • Jul 17, 2019: WeHealth Digital Medicine and French start-up Lucine sign partnership to develop digital therapeutics
  • Jul 16, 2019: Pall chosen as single-source supplier by servier for purpose built end-to-end biomanufacturing facility in Gidy, France
  • Jun 19, 2019: Servier breaks ground of Servier Paris-Saclay Research Institute
  • Jun 06, 2019: Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology
  • Jun 03, 2019: Servier and MBC BioLabs announce winner of the 2019 Servier Golden Ticket
  • Apr 04, 2019: Servier joins access accelerated to fight against non-communicable diseases
  • Jan 31, 2019: Servier: 2017-2018 Financial Figures
  • Dec 04, 2018: Servier joins Embleema's blockchain health consortium to launch a pilot project for blockchain
  • Nov 05, 2018: Servier Launches InnoPreP Chromatography Service under its CDMO Business
  • Sep 19, 2018: Servier and Poietis announce scientific partnership in 4D bioprinting of liver tissues
Section 5 – Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Les Laboratoires Servier SAS, Key Facts
  • Les Laboratoires Servier SAS, Key Employees
  • Les Laboratoires Servier SAS, Major Products and Services
  • Les Laboratoires Servier SAS, History
  • Les Laboratoires Servier SAS, Subsidiaries
  • Les Laboratoires Servier SAS, Key Competitors
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Les Laboratoires Servier SAS, Recent Deals Summary
List of Figures
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Sanofi
  • Pfizer Inc
  • NicOx SA
  • Laboratoires Thea SA
  • Laboratoires Pierre Fabre SA
  • Ipsen SA
Note: Product cover images may vary from those shown
Adroll
adroll